News from Finsen Laboratory Read the latest news about our resarch. Page Content Award winner on the hunt for leukaemia’s evil root Canadian Dr. John E. Dick is to receive Rigshospitalet’s International KFJ Award, and part of the honour is for his work in the fight against leukaemia. 10. January 2017 / 14:10 Big data enables new treatment of aggressive cancers Researchers from the Finsen Laboratory and BRIC in collaboration with researchers from Germany and Norway have developed a new computational method for analysis of large data material from thousands of cancer patients. These ‘big data’ can be used to understand how cancer genes are activated which enables targeted therapy especially for patients with aggressive tumours 22. November 2016 / 9:00 Researchers develop antibody to save cancerous bones A research group lead by Dr. Niels Behrendt and Dr. Lars Engelholm from the Finsen Laboratory and BRIC shows that Osteosarcoma cells degrade the bone tissue through a completely different process than metastasised bone cancer. Through treatment with a specific antibody, the researchers blocked the process and reduced up to 80% of bone degradation in a cancer mouse model. 4. December 2015 / 12:00 Stem-cell protein guarantees life-long blood production A group of researchers at the Finsen Laboratory, Rigshospitalet and BRIC, University of Copenhagen has discovered how a single protein within our blood stem cells, is critical for the ability to uphold the enormous blood production throughout our entire lifetime. The discovery can also provide new knowledge about how to treat diseases in our bone marrow and blood. 22. September 2015 / 13:11 RSS Responsible editor Webgruppen på Rigshospitalet Please give your consent in order to send your message. Please enter a valid email address. Note: This mail is not secure. Your email should therefore not include civil registration numbers or health information.Read how to send secure digital post:https://www.regionh.dk/securemail Write your message: Write your email (Must be filled out): I hereby give my consent to the Capital Region of Denmark to process the information in my enquiry for professional purposes only. Read the terms for your consent Send No e-mail has been registred for this user/group
Award winner on the hunt for leukaemia’s evil root Canadian Dr. John E. Dick is to receive Rigshospitalet’s International KFJ Award, and part of the honour is for his work in the fight against leukaemia. 10. January 2017 / 14:10
Big data enables new treatment of aggressive cancers Researchers from the Finsen Laboratory and BRIC in collaboration with researchers from Germany and Norway have developed a new computational method for analysis of large data material from thousands of cancer patients. These ‘big data’ can be used to understand how cancer genes are activated which enables targeted therapy especially for patients with aggressive tumours 22. November 2016 / 9:00
Researchers develop antibody to save cancerous bones A research group lead by Dr. Niels Behrendt and Dr. Lars Engelholm from the Finsen Laboratory and BRIC shows that Osteosarcoma cells degrade the bone tissue through a completely different process than metastasised bone cancer. Through treatment with a specific antibody, the researchers blocked the process and reduced up to 80% of bone degradation in a cancer mouse model. 4. December 2015 / 12:00
Stem-cell protein guarantees life-long blood production A group of researchers at the Finsen Laboratory, Rigshospitalet and BRIC, University of Copenhagen has discovered how a single protein within our blood stem cells, is critical for the ability to uphold the enormous blood production throughout our entire lifetime. The discovery can also provide new knowledge about how to treat diseases in our bone marrow and blood. 22. September 2015 / 13:11